- Home
- AQST vs BXC Comparison
AQST vs BXC Comparison
Compare AQST & BXC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AQST | BXC |
|---|---|---|
| Founded | 2004 | 2004 |
| Country | United States | United States |
| Employees | N/A | 1700 |
| Industry | Biotechnology: Pharmaceutical Preparations | Wholesale Distributors |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 504.0M | 458.5M |
| IPO Year | 2007 | 2004 |
Fundamental Metrics
Financial Performance| Metric | AQST | BXC |
|---|---|---|
| Price | $4.24 | $48.62 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 2 |
| Target Price | $9.00 | ★ $71.50 |
| AVG Volume (30 Days) | ★ 1.1M | 69.0K |
| Earning Date | 05-01-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.02 |
| Revenue | ★ $67,430,000.00 | N/A |
| Revenue This Year | $10.08 | $5.04 |
| Revenue Next Year | $49.60 | $5.09 |
| P/E Ratio | ★ N/A | $2,602.75 |
| Revenue Growth | ★ 0.77 | N/A |
| 52 Week Low | $2.22 | $44.78 |
| 52 Week High | $7.55 | $88.30 |
Technical Indicators
Market Signals| Indicator | AQST | BXC |
|---|---|---|
| Relative Strength Index (RSI) | 55.89 | 34.03 |
| Support Level | $3.70 | $44.78 |
| Resistance Level | $4.35 | $74.73 |
| Average True Range (ATR) | 0.14 | 2.82 |
| MACD | -0.00 | -0.63 |
| Stochastic Oscillator | 55.56 | 9.16 |
Price Performance
Historical ComparisonAbout AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif, and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.
About BXC Bluelinx Holdings Inc.
BlueLinx Holdings Inc is engaged in the wholesale distribution of residential and commercial building products. Its business products are split into two categories: Structural products include items such as lumber, plywood, oriented strand board, rebar, and remesh, and Specialty products include items such as engineered wood, siding, millwork, outdoor living, specialty lumber and panels, and industrial products. The company's operations are carried out throughout the United States.